Cargando…
Effect of beta‐adrenergic blockade with carvedilol on cachexia in severe chronic heart failure: results from the COPERNICUS trial
BACKGROUND: Cardiac cachexia frequently accompanies the progression of heart failure despite the use of effective therapies for left ventricular dysfunction. Activation of the sympathetic nervous system has been implicated in the pathogenesis of weight loss, but the effects of sympathetic antagonism...
Autores principales: | Clark, Andrew L., Coats, Andrew J.S., Krum, Henry, Katus, Hugo A., Mohacsi, Paul, Salekin, Damien, Schultz, Melissa K., Packer, Milton, Anker, Stefan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566644/ https://www.ncbi.nlm.nih.gov/pubmed/28244261 http://dx.doi.org/10.1002/jcsm.12191 |
Ejemplares similares
-
The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial
por: Eichhorn, Eric J, et al.
Publicado: (2001) -
The Journal of Cachexia, Sarcopenia and Muscle stays the front‐runner in geriatrics and gerontology
por: Anker, Markus S., et al.
Publicado: (2019) -
The 10th year of the Journal of Cachexia, Sarcopenia and Muscle
por: Anker, Markus S., et al.
Publicado: (2020) -
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2021
por: von Haehling, Stephan, et al.
Publicado: (2021) -
Weight loss, malnutrition, and cachexia in COVID‐19: facts and numbers
por: Anker, Markus S., et al.
Publicado: (2020)